Tsuno et al., analyzed the protein cargo of serum-derived sEV from RA patients and showed that the expression of some exosomal proteins, such as Toll-like receptor 3 (TLR3), can distinguish patients with active from those with inactive disease [23]. This evidence concerns the gene TLR3 and rheumatoid arthritis.